{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:56:43Z","timestamp":1793606203513,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Center For Human Reproduction"},{"name":"Foundation for Reproductive Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10815-024-03340-1","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T01:28:14Z","timestamp":1733534894000},"page":"81-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Greater PGT-A utilization in IVF clinics does not improve live birth rates but relates to IVF center ownership: a preliminary report"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4796-7078","authenticated-orcid":false,"given":"Pasquale","family":"Patrizio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Barad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Gleicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,7]]},"reference":[{"issue":"8","key":"3340_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.molmed.2020.11.009","volume":"27","author":"N Gleicher","year":"2021","unstructured":"Gleicher N, Patrizio P, Brivanlou A. Preimplantation genetic testing for aneuploidy \u2013 a castle built on sand. Trends Mol Med. 2021;27(8):731\u201342.","journal-title":"Trends Mol Med"},{"issue":"1","key":"3340_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10815-022-02667-x","volume":"40","author":"A Kucherov","year":"2023","unstructured":"Kucherov A, Fazzari M, Lieman H, Ball GD, Doody K, Jindal S. PGT-A is associated with reduced cumulative live birth rates in first reported stimulation cycles age \u2264 40: an analysis of 133,494 autologous cycles reported to SARS CORS. J Assist Reprod Genet. 2023;40(1):137\u201349.","journal-title":"J Assist Reprod Genet"},{"key":"3340_CR3","first-page":"CD005291","volume":"9","author":"S Cornelisse","year":"2020","unstructured":"Cornelisse S, Zagers M, Kostova E, Fleischer K, van Wely M, Mastenbroek S. Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilization. Cochrane Database Syst Rev. 2020;9:CD005291.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3340_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41591-022-01712-7","volume":"28","author":"N Gleicher","year":"2022","unstructured":"Gleicher N, Albertini DF, Patrizio P, Orvieto R, Adashi E. The uncertain science of preimplantation and prenatal genetic testing. Nat Med. 2022;28(3):442\u20134.","journal-title":"Nat Med"},{"issue":"1","key":"3340_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12958-017-0251-8","volume":"15","author":"N Gleicher","year":"2017","unstructured":"Gleicher N, Metzger J, Croft G, Kushnir V, Barad DH, Hudson C, et al. A single trophectoderm biopsy at blastocyst stage is mathematically unable to determine embryo ploidy accurately enough for clinical use. Reprod Biol Endocrinol. 2017;15(1):33.","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"3340_CR6","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/humrep\/deac063","volume":"37","author":"DH Barad","year":"2022","unstructured":"Barad DH, Albertini DF, Molinari E, Gleicher N. IVF outcomes of embryos with abnormal PGT-A biopsy previously refused transfer: a prospective cohort study. Hum Reprod. 2022;37(6):1194\u2013206.","journal-title":"Hum Reprod"},{"key":"3340_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12958-023-01077-7","volume":"21","author":"N Gleicher","year":"2023","unstructured":"Gleicher N, Patrizio P, Mochizuki L, Barad DH. Previously reported and here added cases demonstrate euploid pregnancies followed by PGT-A as \u201cmosaic\u201d as well as \u201caneuploid\u201d designated embryos. Reprod Biol Endocrinol. 2023;21:25.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2S","key":"3340_CR8","first-page":"2","volume":"4","author":"JS Hynes","year":"2023","unstructured":"Hynes JS, Forman EJ. Transfer of the fittest: using preimplantation genetic testing for aneuploidy to select embryo(s) most likely to lead to live birth. F S Sci. 2023;4(2S):2\u20136.","journal-title":"F S Sci"},{"key":"3340_CR9","unstructured":"Centers for Disease Control and Prevention. 2018 Assisted Reproductive Technology Fertility Clinic Success Rates Report. Atlanta (GA): US Dept of Health and Human Services. 2020."},{"issue":"1","key":"3340_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10815-022-02683-x","volume":"40","author":"S Ohishi","year":"2023","unstructured":"Ohishi S, Otani T. Preimplantation genetic testing for aneuploidy: helpful but not first choice. J Assist Reprod Genet. 2023;40(1):161\u20138.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"3340_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10815-022-02399-y","volume":"39","author":"P Patrizio","year":"2022","unstructured":"Patrizio P, Albertini DF, Gleicher N, Caplan A. The changing world of IVF: the pros and cons of new business models offering assisted reproductive technology. J Assist Reprod Genet. 2022;39(2):305\u201313.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"3340_CR12","doi-asserted-by":"publisher","first-page":"hoz017","DOI":"10.1093\/hropen\/hoz017","volume":"2019","author":"N Gleicher","year":"2019","unstructured":"Gleicher N, Kushnir VA, Barad DH. Worldwide decline of IVF birth rates and its probable causes. Hum Reprod Open. 2019;2019(3):hoz017.","journal-title":"Hum Reprod Open"},{"issue":"3","key":"3340_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10815-022-02439-7","volume":"39","author":"A Von Schondord-Gleicher","year":"2022","unstructured":"Von Schondord-Gleicher A, Mochizuki L, Orvieto R, Patrizio P, Caplan AS, Gleicher N. Revisiting selected ethical aspects of current in vitro fertilization (IVF) practice. J Assist Reprod Genet. 2022;39(3):591\u2013604.","journal-title":"J Assist Reprod Genet"},{"issue":"22","key":"3340_CR14","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1056\/NEJMsb2101718","volume":"385","author":"S Mastenbroek","year":"2021","unstructured":"Mastenbroek S, de Wert G, Adashi EY. The imperative of responsible innovation in reproductive Medicine. N Engl J Med. 2021;385(22):2096\u2013100.","journal-title":"N Engl J Med"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-024-03340-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-024-03340-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-024-03340-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T12:53:14Z","timestamp":1738932794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-024-03340-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,7]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3340"],"URL":"https:\/\/doi.org\/10.1007\/s10815-024-03340-1","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,7]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NG and DHB are listed as co-owners of several already awarded US patents claiming benefits from androgen supplementation in women with infertility conditions and perimenopausal hypo-androgenism-induced sexual dysfunction. Other patents relate to the diagnostic and potential therapeutic benefits of AMH. NG is a shareholder in Fertility Nutraceuticals LLC. NG and DHB, together with other co-inventors, receive patent royalties from Fertility Nutraceuticals, LLC. NG and DHB also received research support, travel funding, and lecture fees over the last 3 years from several pharma companies, however, not in any way related to this manuscript. PP and SD have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Neither the CHR nor the Foundation for Reproductive Medicine had a role in study design, collection of data, interpretation of data, writing of the manuscript, or decisions to submit the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}